1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biopharmaceutical CMO Services Revenue
1.4 Market Analysis by Type
1.4.1 Global Biopharmaceutical CMO Services Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biologics Manufacturing
1.4.3 Biosimilars Manufacturing
1.4.4 Others
1.5 Market by Application
1.5.1 Global Biopharmaceutical CMO Services Market Share by Application: 2021-2026
1.5.2 Clinical Manufacturing
1.5.3 Commercial Manufacturing
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Biopharmaceutical CMO Services Market
1.8.1 Global Biopharmaceutical CMO Services Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Biopharmaceutical CMO Services Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Biopharmaceutical CMO Services Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Biopharmaceutical CMO Services Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Biopharmaceutical CMO Services Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Biopharmaceutical CMO Services Sales Volume Market Share by Region (2015-2020)
3.2 Global Biopharmaceutical CMO Services Sales Revenue Market Share by Region (2015-2020)
3.3 North America Biopharmaceutical CMO Services Sales Volume
3.3.1 North America Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.3.2 North America Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Biopharmaceutical CMO Services Sales Volume
3.4.1 East Asia Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Biopharmaceutical CMO Services Sales Volume (2015-2020)
3.5.1 Europe Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Biopharmaceutical CMO Services Sales Volume (2015-2020)
3.6.1 South Asia Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Biopharmaceutical CMO Services Sales Volume (2015-2020)
3.7.1 Southeast Asia Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Biopharmaceutical CMO Services Sales Volume (2015-2020)
3.8.1 Middle East Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Biopharmaceutical CMO Services Sales Volume (2015-2020)
3.9.1 Africa Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Biopharmaceutical CMO Services Sales Volume (2015-2020)
3.10.1 Oceania Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Biopharmaceutical CMO Services Sales Volume (2015-2020)
3.11.1 South America Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.11.2 South America Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Biopharmaceutical CMO Services Sales Volume (2015-2020)
3.12.1 Rest of the World Biopharmaceutical CMO Services Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Biopharmaceutical CMO Services Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Biopharmaceutical CMO Services Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Biopharmaceutical CMO Services Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Biopharmaceutical CMO Services Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Biopharmaceutical CMO Services Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Biopharmaceutical CMO Services Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Biopharmaceutical CMO Services Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Biopharmaceutical CMO Services Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Biopharmaceutical CMO Services Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Biopharmaceutical CMO Services Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Biopharmaceutical CMO Services Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Biopharmaceutical CMO Services Sales Volume Market Share by Type (2015-2020)
14.2 Global Biopharmaceutical CMO Services Sales Revenue Market Share by Type (2015-2020)
14.3 Global Biopharmaceutical CMO Services Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Biopharmaceutical CMO Services Consumption Volume by Application (2015-2020)
15.2 Global Biopharmaceutical CMO Services Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Biopharmaceutical CMO Services Business
16.1 Lonza
16.1.1 Lonza Company Profile
16.1.2 Lonza Biopharmaceutical CMO Services Product Specification
16.1.3 Lonza Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Samsung BioLogics
16.2.1 Samsung BioLogics Company Profile
16.2.2 Samsung BioLogics Biopharmaceutical CMO Services Product Specification
16.2.3 Samsung BioLogics Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Rentschler Biotechnologie
16.3.1 Rentschler Biotechnologie Company Profile
16.3.2 Rentschler Biotechnologie Biopharmaceutical CMO Services Product Specification
16.3.3 Rentschler Biotechnologie Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Boehringer Ingelheim
16.4.1 Boehringer Ingelheim Company Profile
16.4.2 Boehringer Ingelheim Biopharmaceutical CMO Services Product Specification
16.4.3 Boehringer Ingelheim Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Biomeva
16.5.1 Biomeva Company Profile
16.5.2 Biomeva Biopharmaceutical CMO Services Product Specification
16.5.3 Biomeva Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 AGC Biologics
16.6.1 AGC Biologics Company Profile
16.6.2 AGC Biologics Biopharmaceutical CMO Services Product Specification
16.6.3 AGC Biologics Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Binex
16.7.1 Binex Company Profile
16.7.2 Binex Biopharmaceutical CMO Services Product Specification
16.7.3 Binex Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Catalent
16.8.1 Catalent Company Profile
16.8.2 Catalent Biopharmaceutical CMO Services Product Specification
16.8.3 Catalent Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 JRS Pharma
16.9.1 JRS Pharma Company Profile
16.9.2 JRS Pharma Biopharmaceutical CMO Services Product Specification
16.9.3 JRS Pharma Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 AbbVie
16.10.1 AbbVie Company Profile
16.10.2 AbbVie Biopharmaceutical CMO Services Product Specification
16.10.3 AbbVie Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 WuXi Biologics
16.11.1 WuXi Biologics Company Profile
16.11.2 WuXi Biologics Biopharmaceutical CMO Services Product Specification
16.11.3 WuXi Biologics Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 KBI Biopharma
16.12.1 KBI Biopharma Company Profile
16.12.2 KBI Biopharma Biopharmaceutical CMO Services Product Specification
16.12.3 KBI Biopharma Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 PRA Health Sciences
16.13.1 PRA Health Sciences Company Profile
16.13.2 PRA Health Sciences Biopharmaceutical CMO Services Product Specification
16.13.3 PRA Health Sciences Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 ProBioGen
16.14.1 ProBioGen Company Profile
16.14.2 ProBioGen Biopharmaceutical CMO Services Product Specification
16.14.3 ProBioGen Biopharmaceutical CMO Services Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Biopharmaceutical CMO Services Manufacturing Cost Analysis
17.1 Biopharmaceutical CMO Services Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Biopharmaceutical CMO Services
17.4 Biopharmaceutical CMO Services Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Biopharmaceutical CMO Services Distributors List
18.3 Biopharmaceutical CMO Services Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Biopharmaceutical CMO Services (2021-2026)
20.2 Global Forecasted Revenue of Biopharmaceutical CMO Services (2021-2026)
20.3 Global Forecasted Price of Biopharmaceutical CMO Services (2015-2026)
20.4 Global Forecasted Production of Biopharmaceutical CMO Services by Region (2021-2026)
20.4.1 North America Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.3 Europe Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.7 Africa Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.9 South America Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Biopharmaceutical CMO Services Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Biopharmaceutical CMO Services by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Biopharmaceutical CMO Services by Country
21.2 East Asia Market Forecasted Consumption of Biopharmaceutical CMO Services by Country
21.3 Europe Market Forecasted Consumption of Biopharmaceutical CMO Services by Countriy
21.4 South Asia Forecasted Consumption of Biopharmaceutical CMO Services by Country
21.5 Southeast Asia Forecasted Consumption of Biopharmaceutical CMO Services by Country
21.6 Middle East Forecasted Consumption of Biopharmaceutical CMO Services by Country
21.7 Africa Forecasted Consumption of Biopharmaceutical CMO Services by Country
21.8 Oceania Forecasted Consumption of Biopharmaceutical CMO Services by Country
21.9 South America Forecasted Consumption of Biopharmaceutical CMO Services by Country
21.10 Rest of the world Forecasted Consumption of Biopharmaceutical CMO Services by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer